金币
UID265491
帖子
主题
积分13398
注册时间2016-8-2
最后登录1970-1-1
听众
性别保密
|
欢迎您注册蒲公英
您需要 登录 才可以下载或查看,没有帐号?立即注册
x
美国FDA现场GMP检查的几种结果:
FDA对药厂实施GMP现场检查后,如果发现违反法规现象,则由检察员签署483表,列明违规之处。药厂要针对483表内容提出整改意见,及时反馈给FDA。如果FDA对整改措施满意,发给药厂EIR,意味着该次检查结束。如果不满意,FDA发布警告信或者进口禁令,甚至强制关停。
The Food and Drug Administration issues an EIR(establishment inspection report) after the conclusion of an inspection. The regulator first issues observations on any manufacturing practices that are in violation of the Food, Drug and Cosmetic Act, as part of Form 483. The company then prepares its responses to these observations and submits it to the regulator. If the responses satisfy the U.S. FDA, it closes the inspection. If they don’t, the regulator issues either warning letters or import alerts, or forces a shutdown.
|
|